Global Biological Therapies Outlook for Cancer 2021-2026: Monoclonal Antibodies Segment Expected to Grow to $124.1 billion in 2026 at a CAGR of 12.8% During 2021 to 2026. Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Biological Therapies for Cancer: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. A rise in the...

Stomach Cancer/Gastric Cancer Treatment Market to Reach USD 8.20 Billion by 2026; Rapid Adoption of PD-1 Inhibitors for Treating Gastric Cancers to Boost the Market: Fortune Business Insights™ Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Stomach Cancer Treatment Market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of...